AU2010303020B2 - Bifidobacterium longum ATCC BAA-999 (BL999) and weight control - Google Patents

Bifidobacterium longum ATCC BAA-999 (BL999) and weight control Download PDF

Info

Publication number
AU2010303020B2
AU2010303020B2 AU2010303020A AU2010303020A AU2010303020B2 AU 2010303020 B2 AU2010303020 B2 AU 2010303020B2 AU 2010303020 A AU2010303020 A AU 2010303020A AU 2010303020 A AU2010303020 A AU 2010303020A AU 2010303020 B2 AU2010303020 B2 AU 2010303020B2
Authority
AU
Australia
Prior art keywords
composition
accordance
atcc baa
bifidobacterium longum
longum atcc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010303020A
Other languages
English (en)
Other versions
AU2010303020A1 (en
Inventor
Premysl Bercik
Gabriela Bergonzelli Degonda
Stephen Michael Collins
Elena Verdu De Bercik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41683555&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2010303020(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec SA filed Critical Nestec SA
Publication of AU2010303020A1 publication Critical patent/AU2010303020A1/en
Application granted granted Critical
Publication of AU2010303020B2 publication Critical patent/AU2010303020B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2010303020A 2009-09-30 2010-09-28 Bifidobacterium longum ATCC BAA-999 (BL999) and weight control Ceased AU2010303020B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09171866A EP2308499A1 (en) 2009-09-30 2009-09-30 Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
EP09171866.8 2009-09-30
PCT/EP2010/064348 WO2011039176A1 (en) 2009-09-30 2010-09-28 Bifidobacterium longum atcc baa-999 (bl999) and weight control

Publications (2)

Publication Number Publication Date
AU2010303020A1 AU2010303020A1 (en) 2012-04-19
AU2010303020B2 true AU2010303020B2 (en) 2014-11-20

Family

ID=41683555

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010303020A Ceased AU2010303020B2 (en) 2009-09-30 2010-09-28 Bifidobacterium longum ATCC BAA-999 (BL999) and weight control

Country Status (15)

Country Link
US (1) US20120244125A1 (enExample)
EP (2) EP2308499A1 (enExample)
JP (1) JP5911424B2 (enExample)
CN (1) CN102665737A (enExample)
AR (1) AR078485A1 (enExample)
AU (1) AU2010303020B2 (enExample)
BR (1) BR112012007109A2 (enExample)
CA (1) CA2775976A1 (enExample)
CL (1) CL2012000809A1 (enExample)
IN (1) IN2012DN02463A (enExample)
MX (1) MX2012003612A (enExample)
PH (1) PH12012500569A1 (enExample)
RU (1) RU2567660C2 (enExample)
SG (1) SG10201406169VA (enExample)
WO (1) WO2011039176A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5615285B2 (ja) * 2010-03-18 2014-10-29 森永乳業株式会社 貧血の予防又は治療用組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
FI20116008A0 (fi) * 2011-10-12 2011-10-12 Maeyrae Maekinen Annika Viskeraalisen rasvan estäminen ja diagnostisointi
PL2919796T3 (pl) 2012-11-19 2021-09-27 Université Catholique de Louvain Zastosowanie bakterii akkermansia w leczeniu zaburzeń metabolicznych
AU2014225786B2 (en) 2013-03-08 2017-10-12 Axiom Foods, Inc. Rice protein supplements
JP6234331B2 (ja) * 2014-06-13 2017-11-22 森永乳業株式会社 統合失調症治療剤
TWI572713B (zh) * 2014-10-31 2017-03-01 豐華生物科技股份有限公司 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用
JP6650728B2 (ja) * 2015-03-06 2020-02-19 株式会社ファンケル ダイエット用の製剤
CA3006176C (en) * 2015-12-11 2023-10-31 Alimentary Health Limited Bifidobacterium longum for treating obesity and associated metabolic disorders
JP6847577B2 (ja) * 2015-12-28 2021-03-24 森永乳業株式会社 ビフィドバクテリウム属細菌および／または乳酸菌の増殖促進および／または減少抑制剤
ES2979098T3 (es) * 2016-04-14 2024-09-24 Int N&H Denmark Aps Bifidobacterias para aumentar la masa corporal magra
IT201600105831A1 (it) * 2016-10-20 2018-04-20 Probiotical Spa Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo
KR101920219B1 (ko) * 2017-03-08 2018-11-20 서울대학교산학협력단 비피더스균을 포함하는 비만 예방 또는 개선용 조성물
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
US11833178B2 (en) 2017-08-25 2023-12-05 University College Cork—National University of Ireland, Cork Bifidobacterium longum for treating obesity and weight management
US20200261516A1 (en) * 2017-10-31 2020-08-20 Morinaga Milk Industry Co., Ltd. Composition for Increasing Muscle Mass
EP3713587B1 (en) 2017-11-24 2024-03-27 University College Cork-National University of Ireland, Cork A composition comprising a cohort of bacteria
KR102156399B1 (ko) * 2018-04-11 2020-09-16 한국생명공학연구원 비만의 예방 또는 치료 효과를 가지는 신규 비피도박테리움 롱검 균주 또는 락토바실러스 람노서스 균주 및 이의 용도
CN111187734A (zh) * 2019-12-25 2020-05-22 生合生物科技（扬州）有限公司 长双歧杆菌bl986、由其制备的冻干粉及冻干粉的应用
JP7475155B2 (ja) * 2020-02-14 2024-04-26 森永乳業株式会社 持久力向上用組成物
US20230090660A1 (en) * 2020-05-20 2023-03-23 Societe Des Produits Nestle S.A. Beneficial effect of poaceae and/or leguminoseae fiber on survivability and metabolic activity of bifidobacterium longum
EP4070670A1 (en) 2021-04-08 2022-10-12 University College Cork-National University of Ireland Cork Lacticaseibacillus paracasei em025-11 and uses thereof
WO2026017760A1 (en) 2024-07-16 2026-01-22 University College Cork - National University Of Ireland, Cork Bacterial compositions, and uses thereof for treating or preventing an immune mediated disease
WO2026062250A2 (en) 2024-09-19 2026-03-26 Teagasc - Agriculture And Food Development Authority Probiotic compositions and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181170A2 (en) * 1984-11-05 1986-05-14 Kabushiki Kaisya Advance Hypocholesterolemically active products
WO2007093619A1 (en) * 2006-02-15 2007-08-23 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2687229B2 (ja) * 1988-11-11 1997-12-08 株式会社ヤクルト本社 血圧降下剤
JP4280016B2 (ja) * 2002-02-28 2009-06-17 雪印乳業株式会社 糖尿病合併症予防・改善・治療剤
JP2003252771A (ja) * 2002-03-04 2003-09-10 Snow Brand Milk Prod Co Ltd 加齢に伴う代謝異常疾患の予防・改善・治療剤
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
JP2007169200A (ja) * 2005-12-21 2007-07-05 Morinaga Milk Ind Co Ltd インフルエンザ感染予防のための医薬及び飲食品
MX2008009726A (es) * 2006-01-27 2009-03-05 Danisco Uso de microorganismos probioticos para el tratamiento y prevencion de la obesidad y trastornos relacionados.
US20090170772A1 (en) * 2006-03-31 2009-07-02 Morinaga Milk Industry Co., Ltd. Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
KR20080075971A (ko) * 2007-02-14 2008-08-20 (주)네오팜 프로바이오틱스 복합 제제
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
UA30077U (uk) * 2007-10-18 2008-02-11 Одесская Национальная Академия Пищевых Технологий Композиція для йогурту діабетичного призначення
UA31009U (uk) * 2007-10-18 2008-03-25 Одесская Национальная Академия Пищевых Технологий Кисломолочний напій діабетичного призначення
JP2009143820A (ja) * 2007-12-12 2009-07-02 Tsujido Chemical Corp 高尿酸血症の予防または改善剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181170A2 (en) * 1984-11-05 1986-05-14 Kabushiki Kaisya Advance Hypocholesterolemically active products
WO2007093619A1 (en) * 2006-02-15 2007-08-23 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity

Also Published As

Publication number Publication date
MX2012003612A (es) 2012-04-19
RU2012117804A (ru) 2013-11-20
EP2308499A1 (en) 2011-04-13
JP2013506631A (ja) 2013-02-28
AU2010303020A1 (en) 2012-04-19
PH12012500569A1 (en) 2012-10-22
US20120244125A1 (en) 2012-09-27
AR078485A1 (es) 2011-11-09
SG10201406169VA (en) 2014-11-27
CN102665737A (zh) 2012-09-12
CA2775976A1 (en) 2011-04-07
WO2011039176A1 (en) 2011-04-07
JP5911424B2 (ja) 2016-04-27
CL2012000809A1 (es) 2012-07-13
IN2012DN02463A (enExample) 2015-05-22
RU2567660C2 (ru) 2015-11-10
BR112012007109A2 (pt) 2016-07-05
EP2482829A1 (en) 2012-08-08

Similar Documents

Publication Publication Date Title
RU2567660C2 (ru) Bifidobacterium longum ATCC BAA-999 (BL999) И КОНТРОЛИРОВАНИЕ ВЕСА
US8454949B2 (en) Lactobacillus helveticus CNCM I-4095 and weight control
AU2010213009B2 (en) Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
AU2008288581B2 (en) Lactobacillus rhamnosus and weight control
AU2010213010B2 (en) Lactobacillus rhamnosus CNCM I-4096 and weight control
CN102026554A (zh) 副干酪乳杆菌与体重控制

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired